Phagocytosis of Glioma Cells Enhances the Immunosuppressive Phenotype of Bone Marrow–Derived Macrophages

Author:

Wu Min123ORCID,Wu Lingxiang123ORCID,Wu Wei123ORCID,Zhu Mengyan123ORCID,Li Jianyu4ORCID,Wang Ziyu23ORCID,Li Jie23ORCID,Ding Rong23ORCID,Liang Yuan23ORCID,Li Liangyu23ORCID,Zhang Tingting23ORCID,Huang Bin23ORCID,Cai Yun23ORCID,Li Kening23ORCID,Li Lu23ORCID,Zhang Rui23ORCID,Hu Baoli56ORCID,Lin Fan78ORCID,Wang Xiuxing9ORCID,Zheng Siyuan1011ORCID,Chen Jian4ORCID,You Yongping312ORCID,Jiang Tao13ORCID,Zhang Junxia312ORCID,Chen Hongshan1415ORCID,Wang Qianghu123ORCID

Affiliation:

1. 1The Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing, China.

2. 2Department of Bioinformatics, Nanjing Medical University, Nanjing, China.

3. 3Institute for Brain Tumors, Jiangsu Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, China.

4. 4Chinese Institute for Brain Research Beijing (CIBR), Beijing, China.

5. 5Department of Neurological Surgery, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.

6. 6Division of Pediatric Neurosurgery, UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania.

7. 7Department of Cell Biology, School of Basic Medical Sciences, Nanjing Medical University, Nanjing, China.

8. 8Institute for Brain Tumors and Key Laboratory of Rare Metabolic Diseases, Nanjing Medical University, Nanjing, China.

9. 9School of Basic Medical Sciences, Nanjing Medical University, Nanjing, China.

10. 10Greehey Children's Cancer Research Institute, UT Health San Antonio, San Antonio, Texas.

11. 11Department of Population Health Sciences, UT Health San Antonio, San Antonio, Texas.

12. 12Department of Neurosurgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.

13. 13Beijing Neurosurgical Institute, Capital Medical University, Beijing, China.

14. 14Key Laboratory of Cardiovascular and Cerebrovascular Medicine, School of Pharmacy, Nanjing Medical University, Nanjing, China.

15. 15Department of Cardiothoracic Surgery, the Second Affiliated Hospital of Nanjing Medical University, Nanjing, China.

Abstract

AbstractTumor-associated macrophages (TAM) play a crucial role in immunosuppression. However, how TAMs are transformed into immunosuppressive phenotypes and influence the tumor microenvironment (TME) is not fully understood. Here, we utilized single-cell RNA sequencing and whole-exome sequencing data of glioblastoma (GBM) tissues and identified a subset of TAMs dually expressing macrophage and tumor signatures, which were termed double-positive TAMs. Double-positive TAMs tended to be bone marrow–derived macrophages (BMDM) and were characterized by immunosuppressive phenotypes. Phagocytosis of glioma cells by BMDMs in vitro generated double-positive TAMs with similar immunosuppressive phenotypes to double-positive TAMs in the GBM TME of patients. The double-positive TAMs were transformed into M2-like macrophages and drove immunosuppression by expressing immune-checkpoint proteins CD276, PD-L1, and PD-L2 and suppressing the proliferation of activated T cells. Together, glioma cell phagocytosis by BMDMs in the TME leads to the formation of double-positive TAMs with enhanced immunosuppressive phenotypes, shedding light on the processes driving TAM-mediated immunosuppression in GBM.Significance:Bone marrow–derived macrophages phagocytose glioblastoma cells to form double-positive cells, dually expressing macrophage and tumor signatures that are transformed into M2-like macrophages and drive immunosuppression.

Funder

National Natural Science Foundation of China

Jiangsu Provincial Key Research and Development Program

Basic Research Program of Jiangsu Province

Science and Technology Support Program of Jiangsu Province

Major Research Plan

National Key Research and Development Program of China

Priority Academic Program Development of Jiangsu Higher Education Institutions

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3